WO1994024961A1 - Covered stent and stent delivery device - Google Patents
Covered stent and stent delivery device Download PDFInfo
- Publication number
- WO1994024961A1 WO1994024961A1 PCT/US1994/000604 US9400604W WO9424961A1 WO 1994024961 A1 WO1994024961 A1 WO 1994024961A1 US 9400604 W US9400604 W US 9400604W WO 9424961 A1 WO9424961 A1 WO 9424961A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- wall
- thread elements
- polymeric material
- hose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
Definitions
- the present invention relates to a stent which can be used within a vessel of the body of a living animal or a living human.
- This invention also relates to a device for delivering the stent to the treatment site.
- the stent includes a flexible tubular body which has a specific diameter at an unloaded state but which can be contracted to a smaller diameter by the application of force such as by radially compressing the stent or by pulling the ends of the stent apart. This feature makes the stent particularly useful for mechanical translu inal implantation in biliary ducts, respiratory tracts, the esophagus, blood vessels or the like.
- the stent delivery device includes a first tube having a central lumen for accommodating a guidewire and a flexible hose folded over itself and removably surrounding the first tube.
- the stent is placed around the first tube and held in a radially contracted state by the flexible hose. In this manner, the stent can be delivered percutaneously and transluminally to a treatment site in a body vessel.
- the stent is deployed by rolling the flexible hose off of the stent to allow the stent to radially self- expand. Once the stent is deployed, the stent delivery device can be withdrawn.
- Prior radially self-expanding stents have an open mesh construction. After positioning such a stent in a body vessel, tissue may grow through the spaces between the wires of the stent. In many applications, such an occurrence is not detrimental to the efficacy of the stent. Indeed in many cases such tissue ingrowth is desirable because it helps to keep the stent in place preventing migration of the stent.
- tissue ingrowth could be detrimental.
- the stent is to be placed in a body passage that has tumor growth therein to maintain the patency of the body passage, tumor ingrowth through the stent would limit the effectiveness of the stent. Indeed tumor ingrowth could completely block the body vessel. In addition, such tumor ingrowth would permanently
- Prior delivery devices for radially self- expanding stents generally perform in accordance with their intended purposes.
- Typical prior delivery devices have a moveable tubular member that constrains the stent in a contracted state on an inner catheter.
- the tubular member is removed from contact with the stent to allow the stent to be deployed.
- the tubular member is folded over itself to form a double-walled section.
- prior delivery devices may not be totally effective in delivering a stent to a treatment site. For instance, friction between the walls of the double-walled section of the moveable tubular member as the walls move past each other can make removal of the tubular member from the stent difficult.
- a stent that will maintain the patency of a body vessel and reduce the tissue ingrowth through the stent. It would also be desirable to provide a stent that is removably placeable within a body vessel.
- the covered stent comprises a flexible tubular body, the diameter of which can be changed by radial compression of the stent or by axial movement of the ends of the body relative to each other.
- the covered stent takes on a specified diameter when it is left in an unloaded condition free of external forces.
- the body is composed of several individual, rigid but flexible thread elements each of which extends in a helix configuration with the center line of the body as a common axis. A number of such thread elements have the same direction of winding but are displaced axially relative to each other.
- the remaining thread elements have the opposite direction of winding and are also axially displaced to each other. Thus, each thread element crosses a number of other thread elements in an over and under braided configuration.
- the stent is also covered with a continuous and flexible polymeric matrix that is preferably silicone rubber. This covering limits tissue ingrowth through the stent when the stent is implanted in a body vessel.
- the film is preferably applied to the stent by dip coating the stent in a bath of silicone rubber and an organic solvent. The thickness of the film can be controlled by the ratio of the silicone rubber and organic solvent in the bath and by the number of dip coatings to which the stent is subjected.
- the stent delivery device includes an elongate and flexible length of inner tubing with a central lumen for accommodating a guidewire.
- the stent is placed on this tubing in a radially contracted state for transport to the treatment site.
- a flexible hose surrounds the tubing and is folded over itself to form a double-walled section.
- This double-walled section surrounds and confines the stent in a radially contracted state on the tubing.
- at least that portion of the hose that contacts itself in the double-walled section is lubricous.
- This lubricous characteristic can be achieved by placing a lubricous coating on the surface of the hose that contacts itself in the double-walled section of the hose, by injecting a lubricous liquid into the space between the walls of the double-walled section or by forming the flexible hose from a naturally lubricous material.
- the flexible hose When it is desired to deploy the stent at a treatment site, the flexible hose is rolled back proximally to first expose the distal end of the stent. This allows the operator of the stent delivery device first to align properly the distal portion of the stent in the body vessel. When proper alignment is obtained, the operator can continue to roll the flexible hose proximally to completely uncover the stent and allow it to radially self- expand into engagement with the vessel wall.
- FIG. 1 is a perspective view of the covered stent of this invention clearly showing the braided configuration of the thread elements
- FIG. 2 is a perspective view of the covered stent of this invention in a radially contracted state clearly showing the braided configuration of the thread elements;
- FIG. 3 is a cross-sectional view taken along line 3-3 in FIG. 9.
- FIG. 4 is a detailed view in perspective of a portion of the stent of this invention without the covering to show the braided configuration of the thread elements;
- FIG. 5 is a detailed sectional view of a portion of the stent of this invention without the covering to show the braided configuration of the thread elements;
- FIG. 6 is a diagrammatic sectional view of a portion of the covered stent of this invention showing the flexible polymeric matrix located along the exterior of the stent;
- FIG. 7 is a view similar to the view of FIG. 6 with the flexible polymeric matrix located along the interior of the stent;
- FIG. 8 is a side view of the stent delivery device of this invention with a covered stent loaded therein;
- FIG. 9 is an enlarged side view of the area encircled at 9 in FIG. 8;
- FIG. 10 is an enlarged side view of the area encircled at 10 in FIG. 8;
- FIGS. 11-14 are side views of a distal portion of the stent delivery device and the covered stent of the present invention in various stages of a stent deployment operation in a body vessel. Detailed Description of the Invention
- FIG. 1 there is shown an example of the covered stent 10 of the present invention in an unloaded condition.
- Covered stent 10 is in the form of a cylindrical tubular body.
- Stent 10 is formed by a number of individual thread elements 11. Some of these elements extend in helix configuration in one direction axially displaced in relation to each other having the center longitudinal axis of stent 10 as a common axis. The other elements extend in helix configuration in the opposite direction and are also axially displaced in relation to each other having the center longitudinal axis as a common axis.
- thread elements 11 extend in two directions and cross each other in a braided over and under configuration.
- Thread elements 11 of stent 10 are preferably arranged symmetrically so that the same number of thread elements are used in each direction of a winding. The number of thread elements needed is a function of the diameter of stent 10 in an unloaded condition. For a stent having a diameter of 10 millimeters preferably 24 thread elements are used. Thread elements 11 are helically wound about a cylindrical mandrel. One set of thread elements is wound in one direction while the other set of thread elements is wound in the opposite direction.
- Thread elements 11 should be maintained in tension. Insufficient tensile force may allow the individual thread elements to depart from their configuration causing the braided structure of stent 10 to unravel. When thread elements 11 are properly tensioned, a slight impression is formed in the overlying thread element at each intersection. See FIGS. 4 and 5. Each thread element is thus deformed such that it is bent over other thread elements and partly circumscribes these other thread elements. Generally, only the parts of the respective thread elements lying on top of the crossing thread elements as seen in the radial direction have been subject to bending. These impressions, or saddles, tend to lock the thread elements relative to one another at the intersections. This maintains the stent configuration without the need for welding or other bonding of thread elements 11 at their intersections.
- the axially directed angle between crossing thread elements should be at least 60°, preferably greater than about 90" and even more preferably greater than about 100 * when stent 10 is in an unloaded condition. The greater the angle, the higher the stability of stent 10 under external pressure.
- Thread elements 11 forming stent 10 can be made from a biocompatible and flexible yet rigid material such as various polymers, e.g. Kevlar, and metal such as stainless steel. Other materials include alloys substantially based on cobalt, chromium, nickel and molybdenum, the alloying residue being iron.
- thread elements 11 can be formed from a core and a tubular case surrounding the core. This configuration can enhance the radiopacity of stent 10.
- the core can be constructed of tantalum for radiopacity while the case can be constructed of a cobalt-based alloy such as an alloy available under the brand name "Elgiloy", "Phynox" and "MP35N".
- a clad composite thread element for use in making a stent is described in commonly assigned, co-pending patent application Serial No. 08/006,216 filed on January 19, 1993, which is hereby incorporated by reference.
- the diameter of stent 10 can be changed by radially compressing stent 10 or by axially displacing the ends of stent 10 relative to each other.
- FIG. 2 there is illustrated how stent 10 according to FIG. 1 has been given reduced diameter by moving the ends away from each other in the direction of the arrows. Since stent 10 must engage against the wall of the body vessel in which stent 10 is to be placed with certain pressure in order to remain fixed, the diameter of stent 10 in the radially contracted state must be smaller than the diameter of stent 10 at free expansion.
- Stent 10 is covered by a matrix 15 of a flexible, polymeric material such as silicone rubber, polyurethane or Teflon. Other flexible and biocompatible polymers could also be used. Preferably silicone rubber is used. Matrix 15 can take the form of a film or a braided or woven covering.
- Matrix 15 is preferably applied to stent 10 by dip coating.
- Liquid silicone rubber is mixed with an organic solvent, preferably xylene, to make the silicone rubber flowable.
- an organic solvent preferably xylene
- a ratio of 27% silicone rubber to xylene is preferably used. Using this arrangement only one dip coating is needed to completely cover stent 10.
- a ratio of 18% silicone rubber to xylene is preferably used. Using this arrangement 3 to 5 dip coatings is needed to completely cover stent 10.
- stent 10 can be dip coated by supporting the ends of stent 10, by using an external mandrel or by using an internal mandrel to support stent 10 when it is dipped in the bath of silicone rubber and xylene.
- stent 10 When stent 10 is dip coated by supporting the ends of stent 10, the silicone rubber surrounds thread elements 11 so that the silicone rubber only extends in the interstices between thread elements 11 and there is little excess silicone rubber on the outside or inside of stent 10. See FIG. 3 and FIG. 14.
- the silicone rubber coating tends to extend toward the outside of thread elements 11 forming stent 10. See FIG. 6.
- the silicone rubber When stent 10 is supported by an internal mandrel the silicone rubber tends to extend toward the inside of thread elements 11 forming stent 10. See FIG. 7.
- stent 10 should be supported at the ends or by an external mandrel during the dip coating process. The matrix resulting from this process tends to be stronger and more tear resistant so that it is better able to prevent tissue ingrowth through the interstices between thread elements 11 forming stent 10.
- matrix 15 can also be applied by other methods such as by injection molding or spray coating stent 10 with the polymeric material.
- Stent 10 is placed on a stent delivery device 20 in a radially contracted state for delivery to the treatment site in a body vessel. Stent 10 is carried by the distal portion of delivery device 20. The proximal portion of delivery device 20 generally remains outside of the body for manipulation by the operator.
- Delivery device 20 comprises an elongated, inner tube 30, preferably having an axially extending lumen 35 therethrough.
- a distal portion of inner tube 30 is flexible and can be made from nylon or any other suitably flexible biocompatible polymeric material.
- inner tube 30 is provided with a head 31, through which lumen 35 continues. Head 31 serves to facilitate the insertion of delivery device 20 through a narrow opening in a body vessel.
- the proximal portion of inner tube 30 is preferably formed from stainless steel or some other suitably rigid metal alloy. The proximal end of the distal portion of inner tube 30 is bonded to the distal end of the proximal portion of inner tube 30 in any conventional manner such as by using a standard adhesive.
- a proximal tube 50 surrounds the proximal portion of inner tube 30 in coaxial fashion.
- proximal tube 50 is formed from polyurethane.
- the proximal end of proximal tube 50 is connected to a valve body 40 having a side port 41.
- An extension tube 45 extends from side port 41 to an opening 42. This arrangement allows fluid to be injected through extension tube 45 and between proximal tube 50 and inner tube 30.
- a moveable hose 55 surrounds the distal portion of inner tube 30.
- Hose 55 is rolled over itself to form a double-walled section.
- the proximal end of the inner wall 56 of the double-walled section is connected directly to inner tube 30.
- the proximal end of the outer wall 57 of the double-walled section is connected to the outer surface of the distal portion of proximal tube 50.
- These connections can be achieved by any conventional means such as by a standard adhesive.
- This arrangement allows hose 55 to be rolled off stent 10 placed on the distal portion of inner tube 30.
- outer wall 57 of hose 55 slides proximally over inner wall 56. This causes inner wall 56 to "roll back" off of stent 10.
- At least that portion of inner wall 56 that contacts outer wall 57 in the area where hose 55 is folded over to form the double-walled section should be lubricous.
- the lubricous characteristic can be achieved by adding a lubricous substance*to this surface of hose 55, injecting a lubricous liquid between inner wall 56 and outer wall 57 or forming hose 55 from a naturally slippery material such as Teflon.
- at least the surfaces of inner wall 56 and outer wall 57 that face each other in the double-walled section are coated with a lubricous hydrophilic coating.
- a hydrophilic coating manufactured and sold by The Hydromer Company under the designation 2018-M is used.
- hydrophilic material is added to hose 55 during the assembly of delivery device 20.
- the material used to manufacture hose 55 must be matched to the hydrophilic material used.
- polyurethane works well as the material to form hose 55.
- a blend of 65D and 75D polyurethane provides sufficient flexibility to allow hose 55 to roll over itself yet still be soft enough and compatible with the hydrophilic material so it can be properly coated.
- the blend is composed of 50% 65D polyurethane and 50% 75D polyurethane.
- one side of hose 55 is coated with the hydrophilic material after hose 55 (outer wall 57) has been connected to proximal tube 50.
- Isopropyl alcohol is first applied to one side of hose 55 to clean the surface and remove the waxy film resulting from the plasticizers in the polyurethane.
- That same side of hose 55 is coated with the hydrophilic material.
- the surface of hose 55 should be flushed with alcohol for about 30 seconds.
- that surface of hose 55 should be flushed with the hydrophilic coating for about 30 seconds. It has been found that this technique deposits sufficient hydrophilic material on inner wall 56 and outer wall 57 to allow hose 55 to be rolled back with minimal friction when the hydrophilic material is wet.
- the hydrophilic coating is wetted with physiological saline solution by injecting the solution through extension tube 45, past proximal tube 50 and into the space between inner wall 56 and outer wall 57 of the double-walled section of hose 55. Excess fluid exits from the hole 59 formed toward the distal end of the double-walled section of hose 55.
- a lubricous fluid such as polyethylene glycol can be injected into the space between inner wall 56 and outer wall 57 of the double-walled section to provide the lubricous characteristic of hose 55 in place of adding a lubricous hydrophilic material to hose 55 as described above.
- stent 10 To deliver stent 10 to a treatment site in a body vessel, stent 10 is placed in a radially compressed state in a surrounding relationship to the outer distal end of inner tube 30. Stent 10 is constrained on inner tube 30 by the double-walled section of hose 55. It is important that stent 10 not be confined too tightly on inner tube 30. Hose 55 should apply just enough force to stent 10 to hold stent 10 in place. The double-walled section of hose 55 can be removed from surrounding relation to stent 10 by pulling valve body 40 and proximal tube 50 in a proximal direction. The double-walled section
- Lumen 35 is used to allow stent delivery device 20 to follow a guidewire (not shown) previously inserted percutaneously into the body vessel. Lumen 35 of inner tube 30 can also be used to introduce a contrast fluid to the area around the distal end of delivery device 20 so that the position of delivery device 20 may be easily detected for example by using X-ray technique.
- a covered stent that maintains the patency of a body vessel and reduces tissue ingrowth through the stent.
- a stent delivery device is provided that minimizes friction between moving parts and that can deploy a covered stent at a treatment site with little difficulty.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002158757A CA2158757C (en) | 1993-04-23 | 1994-02-01 | Covered stent and stent delivery device |
EP94906668A EP0695152A1 (en) | 1993-04-23 | 1994-02-01 | Covered stent and stent delivery device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5259593A | 1993-04-23 | 1993-04-23 | |
US08/052,595 | 1993-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994024961A1 true WO1994024961A1 (en) | 1994-11-10 |
Family
ID=21978625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/000604 WO1994024961A1 (en) | 1993-04-23 | 1994-02-01 | Covered stent and stent delivery device |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0695152A1 (en) |
JP (1) | JP2735389B2 (en) |
CA (1) | CA2158757C (en) |
WO (1) | WO1994024961A1 (en) |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0696446A1 (en) * | 1994-08-09 | 1996-02-14 | Olympus Optical Co., Ltd. | Intraluminally indwelling stent and method for manufacturing the same |
WO1996025897A2 (en) * | 1995-02-22 | 1996-08-29 | Menlo Care, Inc. | Covered expanding mesh stent |
WO1996032077A1 (en) * | 1995-04-11 | 1996-10-17 | The University Of Queensland | Artificial graft prosthesis |
US5575818A (en) * | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
US5603698A (en) * | 1993-04-13 | 1997-02-18 | Boston Scientific Corporation | Prosthesis delivery system |
WO1997016133A1 (en) * | 1995-11-01 | 1997-05-09 | Biocompatibles Limited | Braided stent |
US5628788A (en) * | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
EP0804934A2 (en) * | 1996-04-30 | 1997-11-05 | Schneider (Usa) Inc. | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US5700269A (en) * | 1995-06-06 | 1997-12-23 | Corvita Corporation | Endoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
EP0824899A1 (en) * | 1996-08-16 | 1998-02-25 | Schneider (Europe) Ag | Endoprothesis |
US5741333A (en) * | 1995-04-12 | 1998-04-21 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body |
US5755769A (en) * | 1992-03-12 | 1998-05-26 | Laboratoire Perouse Implant | Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof |
US5758562A (en) * | 1995-10-11 | 1998-06-02 | Schneider (Usa) Inc. | Process for manufacturing braided composite prosthesis |
EP0853465A1 (en) * | 1995-09-01 | 1998-07-22 | Emory University | Endovascular support device and method of use |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5843090A (en) * | 1996-11-05 | 1998-12-01 | Schneider (Usa) Inc. | Stent delivery device |
US5849037A (en) * | 1995-04-12 | 1998-12-15 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body, and method for its preparation |
US5888201A (en) * | 1996-02-08 | 1999-03-30 | Schneider (Usa) Inc | Titanium alloy self-expanding stent |
US5902333A (en) * | 1993-04-13 | 1999-05-11 | Boston Scientific Corporation | Prosthesis delivery system with dilating tip |
US5919224A (en) * | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
US5928279A (en) * | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US5980972A (en) * | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US6110198A (en) * | 1995-10-03 | 2000-08-29 | Medtronic Inc. | Method for deploying cuff prostheses |
US6120536A (en) * | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6273895B1 (en) | 1995-06-06 | 2001-08-14 | Corvita Corporation | Method of measuring a body cavity |
AU741137B2 (en) * | 1995-02-22 | 2001-11-22 | Menlo Care, Inc. | Covered expanding mesh stent |
US6432127B1 (en) | 1996-10-11 | 2002-08-13 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
EP1262200A2 (en) * | 1994-06-07 | 2002-12-04 | Genzyme Corporation | Inhibition of platelet adherence and aggregation |
EP1084721A3 (en) * | 1994-12-13 | 2003-05-02 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
US6558414B2 (en) | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
US6579314B1 (en) | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US6592617B2 (en) | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US6770087B2 (en) | 1999-02-02 | 2004-08-03 | Bard Peripheral Vascular, Inc. | Partial encapsulation of stents |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US7004962B2 (en) | 1998-07-27 | 2006-02-28 | Schneider (Usa), Inc. | Neuroaneurysm occlusion and delivery device and method of using same |
US7211109B2 (en) * | 1995-10-11 | 2007-05-01 | Schneider (Usa) Inc. | Braided composite prosthesis |
EP1961401A2 (en) | 2007-02-20 | 2008-08-27 | Cardiatis Société Anonyme | Hyperplasia plaque-preventing stent |
WO2010006786A1 (en) * | 2008-07-15 | 2010-01-21 | Acandis Gmbh & Co. Kg | Implant with a braided mesh structure and method for producing such an implant |
US7819912B2 (en) | 1998-03-30 | 2010-10-26 | Innovational Holdings Llc | Expandable medical device with beneficial agent delivery mechanism |
US7820193B2 (en) | 1993-07-19 | 2010-10-26 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic compositions and methods of use |
US7850728B2 (en) | 2000-10-16 | 2010-12-14 | Innovational Holdings Llc | Expandable medical device for delivery of beneficial agent |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
US8187321B2 (en) | 2000-10-16 | 2012-05-29 | Innovational Holdings, Llc | Expandable medical device for delivery of beneficial agent |
US8197881B2 (en) | 2003-09-22 | 2012-06-12 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US8303609B2 (en) | 2000-09-29 | 2012-11-06 | Cordis Corporation | Coated medical devices |
US8337650B2 (en) | 1995-03-10 | 2012-12-25 | Bard Peripheral Vascular, Inc. | Methods for making a supported graft |
US8349390B2 (en) | 2002-09-20 | 2013-01-08 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US8361537B2 (en) | 1998-03-30 | 2013-01-29 | Innovational Holdings, Llc | Expandable medical device with beneficial agent concentration gradient |
US8556954B2 (en) | 2000-03-27 | 2013-10-15 | Neovasc Medical Ltd | Methods for treating abnormal growths in the body using a flow reducing implant |
US8617441B2 (en) | 1995-03-10 | 2013-12-31 | Bard Peripheral Vascular, Inc. | Methods for making an encapsulated stent |
US8945202B2 (en) | 2009-04-28 | 2015-02-03 | Endologix, Inc. | Fenestrated prosthesis |
US9393100B2 (en) | 2010-11-17 | 2016-07-19 | Endologix, Inc. | Devices and methods to treat vascular dissections |
US9549835B2 (en) | 2011-03-01 | 2017-01-24 | Endologix, Inc. | Catheter system and methods of using same |
US9579103B2 (en) | 2009-05-01 | 2017-02-28 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US9700701B2 (en) | 2008-07-01 | 2017-07-11 | Endologix, Inc. | Catheter system and methods of using same |
US9757262B2 (en) | 2009-07-15 | 2017-09-12 | Endologix, Inc. | Stent graft |
CN107249654A (en) * | 2015-03-12 | 2017-10-13 | 犹他-仁荷Dds及新医疗技术开发共同研究所 | Cell spaces are coated with the support of functional materials |
US9907642B2 (en) | 2009-07-27 | 2018-03-06 | Endologix, Inc. | Stent graft |
US10245166B2 (en) | 2008-02-22 | 2019-04-02 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US11129737B2 (en) | 2015-06-30 | 2021-09-28 | Endologix Llc | Locking assembly for coupling guidewire to delivery system |
US11406518B2 (en) | 2010-11-02 | 2022-08-09 | Endologix Llc | Apparatus and method of placement of a graft or graft system |
US11723783B2 (en) | 2019-01-23 | 2023-08-15 | Neovasc Medical Ltd. | Covered flow modifying apparatus |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014148122A1 (en) | 2013-03-18 | 2014-09-25 | 株式会社パイオラックスメディカルデバイス | Stent |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1205743A (en) * | 1966-07-15 | 1970-09-16 | Nat Res Dev | Surgical dilator |
DE3329176C1 (en) * | 1983-08-12 | 1984-11-22 | Sterimed Gesellschaft für medizinischen Bedarf mbH, 6600 Saarbrücken | Medical device with an insertion aid |
WO1988001924A1 (en) * | 1986-09-12 | 1988-03-24 | Raychem Corporation | Manipulator |
GB2195257A (en) * | 1986-09-30 | 1988-04-07 | Medinvent Sa | Transluminal implantation |
DE3918736A1 (en) * | 1989-06-08 | 1990-12-13 | Christian Dr Vallbracht | PTFE coating for metal mesh prosthesis used in artery expansion - internal and external coatings are applied to mesh and prevent thrombosis and further arterial restriction |
EP0435518A1 (en) * | 1989-12-29 | 1991-07-03 | Med Institute, Inc. | A flexible, kink-resistant catheter |
DE4022956A1 (en) * | 1990-07-19 | 1992-02-06 | Sebastian Dr Freudenberg | Simply positioned endo-luminal body - consists of thermoplastic-coated resistance wire with terminals, formed into cage-like structure, and placed over inflatable balloon |
EP0481365A1 (en) * | 1990-10-13 | 1992-04-22 | Angiomed Ag | Device for expanding a stenosis in a body duct |
WO1992021399A1 (en) * | 1991-06-07 | 1992-12-10 | Rtc Inc. | Non-contaminating probe |
-
1994
- 1994-02-01 WO PCT/US1994/000604 patent/WO1994024961A1/en not_active Application Discontinuation
- 1994-02-01 CA CA002158757A patent/CA2158757C/en not_active Expired - Fee Related
- 1994-02-01 EP EP94906668A patent/EP0695152A1/en not_active Ceased
- 1994-02-01 JP JP52422594A patent/JP2735389B2/en not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1205743A (en) * | 1966-07-15 | 1970-09-16 | Nat Res Dev | Surgical dilator |
DE3329176C1 (en) * | 1983-08-12 | 1984-11-22 | Sterimed Gesellschaft für medizinischen Bedarf mbH, 6600 Saarbrücken | Medical device with an insertion aid |
WO1988001924A1 (en) * | 1986-09-12 | 1988-03-24 | Raychem Corporation | Manipulator |
GB2195257A (en) * | 1986-09-30 | 1988-04-07 | Medinvent Sa | Transluminal implantation |
DE3918736A1 (en) * | 1989-06-08 | 1990-12-13 | Christian Dr Vallbracht | PTFE coating for metal mesh prosthesis used in artery expansion - internal and external coatings are applied to mesh and prevent thrombosis and further arterial restriction |
EP0435518A1 (en) * | 1989-12-29 | 1991-07-03 | Med Institute, Inc. | A flexible, kink-resistant catheter |
DE4022956A1 (en) * | 1990-07-19 | 1992-02-06 | Sebastian Dr Freudenberg | Simply positioned endo-luminal body - consists of thermoplastic-coated resistance wire with terminals, formed into cage-like structure, and placed over inflatable balloon |
EP0481365A1 (en) * | 1990-10-13 | 1992-04-22 | Angiomed Ag | Device for expanding a stenosis in a body duct |
WO1992021399A1 (en) * | 1991-06-07 | 1992-12-10 | Rtc Inc. | Non-contaminating probe |
Cited By (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5755769A (en) * | 1992-03-12 | 1998-05-26 | Laboratoire Perouse Implant | Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof |
US6019787A (en) * | 1992-03-12 | 2000-02-01 | Laboratoire Perouse Implant | Fitting tool for use of an expansible endoprosthesis for a human or animal tubular organ |
US5902333A (en) * | 1993-04-13 | 1999-05-11 | Boston Scientific Corporation | Prosthesis delivery system with dilating tip |
US5603698A (en) * | 1993-04-13 | 1997-02-18 | Boston Scientific Corporation | Prosthesis delivery system |
US5984964A (en) * | 1993-04-13 | 1999-11-16 | Boston Scientific Corporation | Prothesis delivery system |
US7820193B2 (en) | 1993-07-19 | 2010-10-26 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic compositions and methods of use |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
EP1262200A2 (en) * | 1994-06-07 | 2002-12-04 | Genzyme Corporation | Inhibition of platelet adherence and aggregation |
EP1262200A3 (en) * | 1994-06-07 | 2003-03-12 | Genzyme Corporation | Inhibition of platelet adherence and aggregation |
EP0696446A1 (en) * | 1994-08-09 | 1996-02-14 | Olympus Optical Co., Ltd. | Intraluminally indwelling stent and method for manufacturing the same |
EP1084721A3 (en) * | 1994-12-13 | 2003-05-02 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
US5575818A (en) * | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
US5674241A (en) * | 1995-02-22 | 1997-10-07 | Menlo Care, Inc. | Covered expanding mesh stent |
AU719980B2 (en) * | 1995-02-22 | 2000-05-18 | Menlo Care, Inc. | Covered expanding mesh stent |
WO1996025897A3 (en) * | 1995-02-22 | 1996-11-21 | Menlo Care Inc | Covered expanding mesh stent |
AU741137B2 (en) * | 1995-02-22 | 2001-11-22 | Menlo Care, Inc. | Covered expanding mesh stent |
US5968070A (en) * | 1995-02-22 | 1999-10-19 | Cordis Corporation | Covered expanding mesh stent |
WO1996025897A2 (en) * | 1995-02-22 | 1996-08-29 | Menlo Care, Inc. | Covered expanding mesh stent |
US8337650B2 (en) | 1995-03-10 | 2012-12-25 | Bard Peripheral Vascular, Inc. | Methods for making a supported graft |
US8647458B2 (en) | 1995-03-10 | 2014-02-11 | Bard Peripheral Vascular, Inc. | Methods for making a supported graft |
US6579314B1 (en) | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US6740115B2 (en) | 1995-03-10 | 2004-05-25 | C. R. Bard, Inc. | Covered stent with encapsulated ends |
US8617441B2 (en) | 1995-03-10 | 2013-12-31 | Bard Peripheral Vascular, Inc. | Methods for making an encapsulated stent |
WO1996032077A1 (en) * | 1995-04-11 | 1996-10-17 | The University Of Queensland | Artificial graft prosthesis |
US5849037A (en) * | 1995-04-12 | 1998-12-15 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body, and method for its preparation |
US5741333A (en) * | 1995-04-12 | 1998-04-21 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body |
US6237460B1 (en) | 1995-04-12 | 2001-05-29 | Corvita Corporation | Method for preparation of a self-expanding stent for a medical device to be introduced into a cavity of a body |
US6120536A (en) * | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US5700269A (en) * | 1995-06-06 | 1997-12-23 | Corvita Corporation | Endoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability |
US6273895B1 (en) | 1995-06-06 | 2001-08-14 | Corvita Corporation | Method of measuring a body cavity |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
EP0853465A4 (en) * | 1995-09-01 | 1999-10-27 | Univ Emory | Endovascular support device and method of use |
EP0853465A1 (en) * | 1995-09-01 | 1998-07-22 | Emory University | Endovascular support device and method of use |
US6193745B1 (en) | 1995-10-03 | 2001-02-27 | Medtronic, Inc. | Modular intraluminal prosteheses construction and methods |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US6110198A (en) * | 1995-10-03 | 2000-08-29 | Medtronic Inc. | Method for deploying cuff prostheses |
US6123722A (en) * | 1995-10-03 | 2000-09-26 | Medtronics, Inc. | Stitched stent grafts and methods for their fabrication |
US7211109B2 (en) * | 1995-10-11 | 2007-05-01 | Schneider (Usa) Inc. | Braided composite prosthesis |
US5758562A (en) * | 1995-10-11 | 1998-06-02 | Schneider (Usa) Inc. | Process for manufacturing braided composite prosthesis |
WO1997016133A1 (en) * | 1995-11-01 | 1997-05-09 | Biocompatibles Limited | Braided stent |
US5628788A (en) * | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US5888201A (en) * | 1996-02-08 | 1999-03-30 | Schneider (Usa) Inc | Titanium alloy self-expanding stent |
EP0788802A3 (en) * | 1996-02-08 | 2000-04-12 | Schneider (Usa) Inc. | Titanium alloy self-expanding stent |
EP0804934A2 (en) * | 1996-04-30 | 1997-11-05 | Schneider (Usa) Inc. | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US6592617B2 (en) | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US7052513B2 (en) | 1996-04-30 | 2006-05-30 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
EP0804934A3 (en) * | 1996-04-30 | 1999-08-04 | Schneider (Usa) Inc. | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US5891191A (en) * | 1996-04-30 | 1999-04-06 | Schneider (Usa) Inc | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US6786920B2 (en) | 1996-07-03 | 2004-09-07 | Edwards Lifesciences Corporation | Radially expandable stented tubular PTFE grafts |
US5928279A (en) * | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
AU727097B2 (en) * | 1996-08-16 | 2000-11-30 | Schneider (Europe) Gmbh | Endoprosthesis |
EP0824899A1 (en) * | 1996-08-16 | 1998-02-25 | Schneider (Europe) Ag | Endoprothesis |
US6432127B1 (en) | 1996-10-11 | 2002-08-13 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US5843090A (en) * | 1996-11-05 | 1998-12-01 | Schneider (Usa) Inc. | Stent delivery device |
US5980972A (en) * | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
US5919224A (en) * | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
US8052734B2 (en) | 1998-03-30 | 2011-11-08 | Innovational Holdings, Llc | Expandable medical device with beneficial agent delivery mechanism |
US7896912B2 (en) | 1998-03-30 | 2011-03-01 | Innovational Holdings, Llc | Expandable medical device with S-shaped bridging elements |
US8623068B2 (en) | 1998-03-30 | 2014-01-07 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US8206435B2 (en) | 1998-03-30 | 2012-06-26 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US8052735B2 (en) | 1998-03-30 | 2011-11-08 | Innovational Holdings, Llc | Expandable medical device with ductile hinges |
US8439968B2 (en) | 1998-03-30 | 2013-05-14 | Innovational Holdings, Llc | Expandable medical device for delivery of beneficial agent |
US7819912B2 (en) | 1998-03-30 | 2010-10-26 | Innovational Holdings Llc | Expandable medical device with beneficial agent delivery mechanism |
US8361537B2 (en) | 1998-03-30 | 2013-01-29 | Innovational Holdings, Llc | Expandable medical device with beneficial agent concentration gradient |
US7004962B2 (en) | 1998-07-27 | 2006-02-28 | Schneider (Usa), Inc. | Neuroaneurysm occlusion and delivery device and method of using same |
US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
EP1472994A2 (en) | 1998-08-14 | 2004-11-03 | Boston Scientific Scimed, Inc. | Stent-graft-membrane and method of making same |
US6709455B1 (en) | 1998-08-14 | 2004-03-23 | Boston Scientific Scimed, Inc. | Stent-graft-membrane and method of making the same |
US6770087B2 (en) | 1999-02-02 | 2004-08-03 | Bard Peripheral Vascular, Inc. | Partial encapsulation of stents |
US6558414B2 (en) | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
US7914639B2 (en) | 1999-02-02 | 2011-03-29 | Bard Peripheral Vascular, Inc. | Partial encapsulation of stents |
US10213328B2 (en) | 1999-02-02 | 2019-02-26 | Bard Peripheral Vascular, Inc. | Partial encapsulation of stents |
US8617337B2 (en) | 1999-02-02 | 2013-12-31 | Bard Peripheral Vascular, Inc. | Partial encapsulation of stents |
US8556954B2 (en) | 2000-03-27 | 2013-10-15 | Neovasc Medical Ltd | Methods for treating abnormal growths in the body using a flow reducing implant |
US9364354B2 (en) | 2000-03-27 | 2016-06-14 | Neovasc Medical Ltd | Methods for treating abnormal growths in the body using a flow reducing implant |
US10542994B2 (en) | 2000-03-27 | 2020-01-28 | Neovasc Medical Ltd. | Methods for treating abnormal growths in the body using a flow reducing implant |
US8858612B2 (en) | 2000-03-27 | 2014-10-14 | Neovasc Medical Inc. | Methods for treating abnormal growths in the body using a flow reducing implant |
US11497503B2 (en) | 2000-03-27 | 2022-11-15 | Neovasc Medical Ltd. | Methods for treating abnormal growths in the body using a flow reducing implant |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US8303609B2 (en) | 2000-09-29 | 2012-11-06 | Cordis Corporation | Coated medical devices |
US7850728B2 (en) | 2000-10-16 | 2010-12-14 | Innovational Holdings Llc | Expandable medical device for delivery of beneficial agent |
US8187321B2 (en) | 2000-10-16 | 2012-05-29 | Innovational Holdings, Llc | Expandable medical device for delivery of beneficial agent |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
US8349390B2 (en) | 2002-09-20 | 2013-01-08 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US9254202B2 (en) | 2002-09-20 | 2016-02-09 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US8197881B2 (en) | 2003-09-22 | 2012-06-12 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
EP1961401A2 (en) | 2007-02-20 | 2008-08-27 | Cardiatis Société Anonyme | Hyperplasia plaque-preventing stent |
US10245166B2 (en) | 2008-02-22 | 2019-04-02 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
US10512758B2 (en) | 2008-07-01 | 2019-12-24 | Endologix, Inc. | Catheter system and methods of using same |
US9700701B2 (en) | 2008-07-01 | 2017-07-11 | Endologix, Inc. | Catheter system and methods of using same |
WO2010006786A1 (en) * | 2008-07-15 | 2010-01-21 | Acandis Gmbh & Co. Kg | Implant with a braided mesh structure and method for producing such an implant |
US10603196B2 (en) | 2009-04-28 | 2020-03-31 | Endologix, Inc. | Fenestrated prosthesis |
US8945202B2 (en) | 2009-04-28 | 2015-02-03 | Endologix, Inc. | Fenestrated prosthesis |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US9579103B2 (en) | 2009-05-01 | 2017-02-28 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US9757262B2 (en) | 2009-07-15 | 2017-09-12 | Endologix, Inc. | Stent graft |
US9907642B2 (en) | 2009-07-27 | 2018-03-06 | Endologix, Inc. | Stent graft |
US10874502B2 (en) | 2009-07-27 | 2020-12-29 | Endologix Llc | Stent graft |
US11406518B2 (en) | 2010-11-02 | 2022-08-09 | Endologix Llc | Apparatus and method of placement of a graft or graft system |
US9393100B2 (en) | 2010-11-17 | 2016-07-19 | Endologix, Inc. | Devices and methods to treat vascular dissections |
US9549835B2 (en) | 2011-03-01 | 2017-01-24 | Endologix, Inc. | Catheter system and methods of using same |
US10660775B2 (en) | 2011-03-01 | 2020-05-26 | Endologix, Inc. | Catheter system and methods of using same |
US9687374B2 (en) | 2011-03-01 | 2017-06-27 | Endologix, Inc. | Catheter system and methods of using same |
CN107249654A (en) * | 2015-03-12 | 2017-10-13 | 犹他-仁荷Dds及新医疗技术开发共同研究所 | Cell spaces are coated with the support of functional materials |
US11129737B2 (en) | 2015-06-30 | 2021-09-28 | Endologix Llc | Locking assembly for coupling guidewire to delivery system |
US11723783B2 (en) | 2019-01-23 | 2023-08-15 | Neovasc Medical Ltd. | Covered flow modifying apparatus |
Also Published As
Publication number | Publication date |
---|---|
CA2158757A1 (en) | 1994-11-10 |
EP0695152A1 (en) | 1996-02-07 |
CA2158757C (en) | 2000-01-04 |
JPH08504650A (en) | 1996-05-21 |
JP2735389B2 (en) | 1998-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2158757C (en) | Covered stent and stent delivery device | |
US6214040B1 (en) | Sandwich stent with spiraling bands on an outer surface | |
US6183508B1 (en) | Method for treating a vessel with a titanium alloy stent | |
US8529619B2 (en) | Methods for delivering a prosthesis to a site in a body | |
US10004615B2 (en) | Covered stents with degradable barbs | |
US5772668A (en) | Apparatus for placing an endoprosthesis | |
US5662703A (en) | Rolling membrane stent delivery device | |
JP4393655B2 (en) | Self-expanding stent delivery device | |
EP0680734A2 (en) | Endovascular grafting apparatus, system and method and devices for use therewith | |
US7651525B2 (en) | Intraluminal stent assembly and method of deploying the same | |
JP2003265619A (en) | Self-expanding stent delivery system | |
WO2001049214A1 (en) | Apparatus and method for delivering a self-expanding stent on a guide wire | |
WO2001066037A2 (en) | Intraluminal prosthesis | |
EP1588676B1 (en) | Stent-graft assembly with elution openings | |
US20070173862A1 (en) | Flexible support member with high pushability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2158757 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994906668 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994906668 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1994906668 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994906668 Country of ref document: EP |